 Venkat Kalapatapu
Concepts (156)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endovascular Procedures | 8 | 2025 | 193 | 1.930 |
Why?
| | Blood Vessel Prosthesis Implantation | 10 | 2025 | 135 | 1.790 |
Why?
| | Vascular System Injuries | 3 | 2024 | 42 | 1.380 |
Why?
| | Ischemia | 4 | 2017 | 158 | 0.860 |
Why?
| | Vascular Surgical Procedures | 5 | 2024 | 171 | 0.790 |
Why?
| | Aorta, Thoracic | 3 | 2024 | 101 | 0.770 |
Why?
| | Wounds, Nonpenetrating | 2 | 2024 | 86 | 0.770 |
Why?
| | Mesenteric Vascular Occlusion | 1 | 2021 | 6 | 0.730 |
Why?
| | Aortic Aneurysm, Thoracic | 4 | 2025 | 28 | 0.680 |
Why?
| | Endarterectomy, Carotid | 2 | 2014 | 63 | 0.670 |
Why?
| | Carotid Stenosis | 2 | 2014 | 65 | 0.670 |
Why?
| | Blood Vessel Prosthesis | 5 | 2025 | 89 | 0.610 |
Why?
| | Treatment Outcome | 20 | 2025 | 5595 | 0.610 |
Why?
| | Thoracic Injuries | 1 | 2019 | 36 | 0.600 |
Why?
| | Arteries | 1 | 2019 | 93 | 0.570 |
Why?
| | Axillary Vein | 1 | 2017 | 6 | 0.520 |
Why?
| | Brachial Artery | 1 | 2017 | 18 | 0.520 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2017 | 35 | 0.500 |
Why?
| | Peripheral Nervous System Diseases | 1 | 2017 | 60 | 0.490 |
Why?
| | Renal Dialysis | 2 | 2020 | 196 | 0.490 |
Why?
| | Arterial Occlusive Diseases | 4 | 2008 | 85 | 0.450 |
Why?
| | Time Factors | 14 | 2025 | 2991 | 0.450 |
Why?
| | Kidney Failure, Chronic | 1 | 2017 | 210 | 0.440 |
Why?
| | Postoperative Complications | 10 | 2025 | 1099 | 0.440 |
Why?
| | Carotid Artery, Internal | 1 | 2014 | 22 | 0.430 |
Why?
| | Carotid Artery Diseases | 1 | 2014 | 33 | 0.420 |
Why?
| | Endometrial Stromal Tumors | 1 | 2014 | 1 | 0.420 |
Why?
| | Intracranial Hemorrhages | 1 | 2014 | 44 | 0.420 |
Why?
| | Heart Neoplasms | 1 | 2014 | 31 | 0.400 |
Why?
| | Vena Cava, Inferior | 1 | 2014 | 62 | 0.400 |
Why?
| | Lower Extremity | 4 | 2024 | 103 | 0.380 |
Why?
| | Endometrial Neoplasms | 1 | 2014 | 143 | 0.380 |
Why?
| | Retrospective Studies | 16 | 2025 | 6819 | 0.370 |
Why?
| | Risk Factors | 13 | 2025 | 4017 | 0.350 |
Why?
| | Stents | 5 | 2024 | 376 | 0.330 |
Why?
| | Aortic Aneurysm, Abdominal | 2 | 2021 | 52 | 0.320 |
Why?
| | Peripheral Arterial Disease | 3 | 2024 | 84 | 0.320 |
Why?
| | Aged | 16 | 2025 | 10429 | 0.320 |
Why?
| | Tertiary Care Centers | 2 | 2020 | 86 | 0.300 |
Why?
| | Celiac Artery | 1 | 2008 | 8 | 0.290 |
Why?
| | Ligaments | 1 | 2008 | 12 | 0.290 |
Why?
| | Collateral Circulation | 1 | 2008 | 39 | 0.290 |
Why?
| | Angiography, Digital Subtraction | 1 | 2008 | 28 | 0.290 |
Why?
| | Female | 20 | 2025 | 28782 | 0.280 |
Why?
| | Vasodilator Agents | 1 | 2008 | 90 | 0.280 |
Why?
| | Ketorolac Tromethamine | 1 | 2007 | 3 | 0.270 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2007 | 40 | 0.270 |
Why?
| | Carotid Arteries | 1 | 2007 | 77 | 0.260 |
Why?
| | Humans | 24 | 2025 | 53230 | 0.260 |
Why?
| | Middle Aged | 16 | 2025 | 13419 | 0.260 |
Why?
| | Mesenteric Artery, Superior | 2 | 2021 | 12 | 0.250 |
Why?
| | Hemostatic Techniques | 1 | 2006 | 32 | 0.250 |
Why?
| | Length of Stay | 3 | 2020 | 684 | 0.240 |
Why?
| | Risk Assessment | 8 | 2025 | 1368 | 0.240 |
Why?
| | Male | 19 | 2025 | 27435 | 0.230 |
Why?
| | Antioxidants | 1 | 2007 | 264 | 0.230 |
Why?
| | Device Removal | 4 | 2020 | 89 | 0.230 |
Why?
| | Prosthesis Design | 2 | 2024 | 266 | 0.220 |
Why?
| | Hemorrhage | 1 | 2006 | 226 | 0.220 |
Why?
| | Adult | 9 | 2024 | 14534 | 0.210 |
Why?
| | Vascular Patency | 4 | 2020 | 88 | 0.210 |
Why?
| | Oxidative Stress | 1 | 2007 | 819 | 0.190 |
Why?
| | United States Food and Drug Administration | 2 | 2025 | 93 | 0.190 |
Why?
| | Aortic Rupture | 1 | 2021 | 19 | 0.180 |
Why?
| | Reoperation | 3 | 2024 | 476 | 0.170 |
Why?
| | Graft Occlusion, Vascular | 2 | 2020 | 81 | 0.170 |
Why?
| | Regional Blood Flow | 2 | 2021 | 112 | 0.170 |
Why?
| | Clinical Trials as Topic | 2 | 2025 | 466 | 0.160 |
Why?
| | Aged, 80 and over | 6 | 2025 | 3494 | 0.160 |
Why?
| | Injury Severity Score | 1 | 2019 | 166 | 0.150 |
Why?
| | Vena Cava Filters | 1 | 2019 | 31 | 0.150 |
Why?
| | Ultrasonography, Interventional | 1 | 2020 | 138 | 0.150 |
Why?
| | Prosthesis Implantation | 1 | 2019 | 49 | 0.140 |
Why?
| | Patient Acuity | 1 | 2018 | 17 | 0.140 |
Why?
| | Device Approval | 1 | 2017 | 4 | 0.140 |
Why?
| | Databases, Factual | 4 | 2024 | 742 | 0.130 |
Why?
| | Aortic Aneurysm | 1 | 2017 | 29 | 0.130 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2017 | 30 | 0.130 |
Why?
| | United States | 6 | 2025 | 5409 | 0.130 |
Why?
| | Hospital Costs | 1 | 2017 | 74 | 0.130 |
Why?
| | Disease Progression | 1 | 2019 | 880 | 0.120 |
Why?
| | Acute Disease | 1 | 2017 | 393 | 0.120 |
Why?
| | Hemodynamics | 1 | 2017 | 236 | 0.120 |
Why?
| | Acute Kidney Injury | 1 | 2020 | 399 | 0.110 |
Why?
| | Aorta | 2 | 2021 | 172 | 0.110 |
Why?
| | Young Adult | 2 | 2024 | 4511 | 0.100 |
Why?
| | Phlebography | 1 | 2014 | 55 | 0.100 |
Why?
| | Hysterectomy | 1 | 2014 | 91 | 0.100 |
Why?
| | Reperfusion Injury | 1 | 2014 | 82 | 0.100 |
Why?
| | Cerebrovascular Circulation | 1 | 2014 | 132 | 0.100 |
Why?
| | Cardiac Surgical Procedures | 1 | 2014 | 331 | 0.080 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2014 | 647 | 0.080 |
Why?
| | Registries | 3 | 2021 | 652 | 0.080 |
Why?
| | Injections, Intra-Arterial | 1 | 2008 | 14 | 0.070 |
Why?
| | Popliteal Vein | 1 | 2008 | 14 | 0.070 |
Why?
| | Femoral Vein | 1 | 2008 | 39 | 0.070 |
Why?
| | Constriction, Pathologic | 1 | 2008 | 91 | 0.070 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 1180 | 0.070 |
Why?
| | Syndrome | 1 | 2008 | 248 | 0.070 |
Why?
| | Malondialdehyde | 1 | 2007 | 55 | 0.070 |
Why?
| | Endarterectomy | 1 | 2007 | 10 | 0.070 |
Why?
| | Hyperplasia | 1 | 2007 | 98 | 0.070 |
Why?
| | Platelet Activation | 1 | 2007 | 48 | 0.070 |
Why?
| | Prosthesis-Related Infections | 1 | 2008 | 109 | 0.060 |
Why?
| | Severity of Illness Index | 2 | 2007 | 1049 | 0.060 |
Why?
| | Chi-Square Distribution | 2 | 2017 | 291 | 0.060 |
Why?
| | Punctures | 1 | 2006 | 52 | 0.060 |
Why?
| | Femoral Artery | 1 | 2007 | 106 | 0.060 |
Why?
| | Wound Infection | 1 | 2006 | 33 | 0.060 |
Why?
| | Arteriovenous Fistula | 1 | 2006 | 28 | 0.060 |
Why?
| | Equipment Failure | 1 | 2006 | 64 | 0.060 |
Why?
| | Glutathione | 1 | 2007 | 303 | 0.060 |
Why?
| | Aneurysm, False | 1 | 2006 | 44 | 0.060 |
Why?
| | Catheterization | 1 | 2006 | 95 | 0.060 |
Why?
| | Predictive Value of Tests | 1 | 2008 | 934 | 0.060 |
Why?
| | Odds Ratio | 2 | 2017 | 567 | 0.060 |
Why?
| | Equipment Design | 1 | 2006 | 290 | 0.060 |
Why?
| | Endoleak | 1 | 2025 | 3 | 0.060 |
Why?
| | Logistic Models | 2 | 2017 | 947 | 0.050 |
Why?
| | Fibrinolytic Agents | 1 | 2005 | 132 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2007 | 1367 | 0.050 |
Why?
| | Laparotomy | 1 | 2024 | 37 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 1 | 2007 | 1544 | 0.050 |
Why?
| | Emergencies | 1 | 2024 | 78 | 0.050 |
Why?
| | Practice Guidelines as Topic | 1 | 2006 | 502 | 0.050 |
Why?
| | Disease Models, Animal | 1 | 2007 | 1517 | 0.050 |
Why?
| | Rats | 1 | 2007 | 3162 | 0.040 |
Why?
| | Retreatment | 1 | 2021 | 60 | 0.040 |
Why?
| | Cohort Studies | 1 | 2024 | 1557 | 0.040 |
Why?
| | Philadelphia | 1 | 2019 | 13 | 0.040 |
Why?
| | Intensive Care Units | 1 | 2020 | 243 | 0.040 |
Why?
| | Prospective Studies | 1 | 2024 | 2411 | 0.030 |
Why?
| | Quality Indicators, Health Care | 1 | 2018 | 92 | 0.030 |
Why?
| | Hospitals, University | 1 | 2017 | 75 | 0.030 |
Why?
| | Limb Salvage | 1 | 2017 | 43 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2017 | 466 | 0.030 |
Why?
| | Health Status | 1 | 2018 | 306 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2017 | 445 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2017 | 487 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2017 | 274 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2017 | 598 | 0.030 |
Why?
| | Wound Healing | 1 | 2017 | 226 | 0.030 |
Why?
| | Comorbidity | 1 | 2017 | 638 | 0.030 |
Why?
| | Smoking | 1 | 2017 | 526 | 0.020 |
Why?
| | Animals | 1 | 2007 | 13526 | 0.020 |
Why?
| | Alloys | 1 | 2007 | 10 | 0.020 |
Why?
| | Image Enhancement | 1 | 2007 | 49 | 0.020 |
Why?
| | Leg | 1 | 2007 | 123 | 0.020 |
Why?
| | Angioplasty, Balloon | 1 | 2007 | 69 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2008 | 411 | 0.020 |
Why?
| | Infusions, Intra-Arterial | 1 | 2005 | 13 | 0.010 |
Why?
| | Recurrence | 1 | 2007 | 694 | 0.010 |
Why?
| | Angiography | 1 | 2005 | 114 | 0.010 |
Why?
| | Survival Rate | 1 | 2007 | 949 | 0.010 |
Why?
| | Thrombolytic Therapy | 1 | 2005 | 114 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2005 | 2318 | 0.010 |
Why?
|
|
Kalapatapu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|